Assessment
Questionnaire

Have a symptom?
See what questions
a doctor would ask.
 
Articles » Clinical Trials Alzheimer''s Disease and Related Disorders: NIMH
 

Clinical Trials Alzheimer''s Disease and Related Disorders: NIMH

Article title: Clinical Trials Alzheimer''s Disease and Related Disorders: NIMH

Conditions: Alzheimer's Disease, dementia

Source: NIMH


FEATURED STUDIES

Alzheimer's Disease

  • CATIE Alzheimer's Disease Trial.
    Treatment study; outpatient. A long-term study of atypical antipsychotic medications for treating symptoms of delusions, hallucinations, agitation, or aggressive behavior in people with Alzheimer's disease. No age limit. Locations across the U.S.

  • Alzheimer's Disease Study.
    Evaluation study; inpatient and outpatient. Examines whether the medication cyclophosphamide (CytoxanŽ) might help people with mild to moderate severity Alzheimer's disease. This is a 6-month study with both inpatient and outpatient visits. Ages 50-95. NIH Clinical Center, Bethesda, MD.

Memory Disorder

  • Memory and Cognitive Problems.
    Evaluation study; inpatient. Screens people with memory difficulties and tries to find the cause of the problem. This is a 3-week inpatient study, with annual 2-week inpatient visits every year thereafter. Up to age 85. NIH Clinical Center, Bethesda, MD.

Additional NIH Studies

Search ClinicalTrials.gov for more NIH/NIMH studies on Alzheimer's Disease and Related Disorders

Many people experience memory lapses. Some memory problems are serious, and others are not. People who have serious changes in their memory, personality, and behavior may suffer from a form of brain disease called dementia. Dementia seriously affects a person's ability to carry out daily activities. Alzheimer's disease is one of many types of dementia.

ALZHEIMER'S DISEASE (AD) is an age-related and irreversible brain disorder that occurs gradually and results in memory loss, behavior and personality changes, and a decline in thinking abilities. These losses are related to the breakdown of the connections between nerve cells in the brain and the eventual death of many of these cells. About 3 percent of men and women ages 65 to 74 have AD, and nearly half of those age 85 and older may have the disease. It is important to note, however, that AD is not a normal part of aging.

More information on Alzheimer's Disease and Dementia (from NIA/ADEAR)

Posted: November 30, 2001

| NIMH Home | Welcome | News and Events | Clinical Trials | Funding Opportunities |
| For the Public | For Practitioners | For Researchers | Intramural Research |
| Top |

For information about NIMH and its programs, please email, write or phone us.

NIMH Public Inquiries
6001 Executive Boulevard, Rm. 8184, MSC 9663
Bethesda, MD 20892-9663 U.S.A.
Voice (301) 443-4513; Fax (301) 443-4279
TTY (301) 443-8431

[Disclaimer, Copyright, and Privacy Notice]
National Institutes of Health (NIH)
9000 Rockville Pike
Bethesda, Maryland 20892
Department of Health
and Human Services

 

By using this site you agree to our Terms of Use. Information provided on this site is for informational purposes only; it is not intended as a substitute for advice from your own medical team. The information on this site is not to be used for diagnosing or treating any health concerns you may have - please contact your physician or health care professional for all your medical needs. Please see our Terms of Use.

Home | Symptoms | Diseases | Diagnosis | Videos | Tools | Forum | About Us | Terms of Use | Privacy Policy | Site Map | Advertise